Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) has named Bill Meury as its new President and Chief Executive Officer (CEO) and elected him to the company’s Board of Directors, effective immediately. …
Bill Meury Named President and CEO of Incyte Read More
WILMINGTON, DE — Certinal has announced the launch of its new Consent Form Management System (CFMS), offering hospitals a modern solution to inefficient, high-risk consent processes. The platform replaces outdated, …
Certinal Launches Consent Form Management System to Modernize Hospital Workflows Read More
WILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has granted accelerated approval to DATROWAY® (datopotamab deruxtecan-dlnk) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated …
FDA Grants Accelerated Approval for DATROWAY in Advanced EGFR-Mutated Lung Cancer Read More
WILMINGTON, DE — Chase has unveiled significant developments in its premium credit card lineup with the launch of the all-new Sapphire Reserve and Sapphire Reserve for Business. These refreshed offerings …
Chase Expands Premium Card Offerings with Sapphire Reserve Launch Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) announced its Board of Directors has declared a quarterly dividend of $0.75 per share on its Series A preferred …
Onfolio Holdings Declares $0.75 Quarterly Dividend for Series A Preferred Stock Read More
WILMINGTON, DE — The Apache Software Foundation (ASF), a leading authority in open source software development, has unveiled the schedule for its flagship event, Community Over Code North America. The …
Apache Software Foundation Announces Community Over Code North America 2025 Read More WILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has announced a three-month extension for its review of the supplemental New Drug Application (sNDA) for ruxolitinib cream (Opzelura®), submitted …
FDA Extends Review Period for Ruxolitinib Cream for Pediatric Atopic Dermatitis Read More WILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory …
FDA Approves Monjuvi for Treating Relapsed or Refractory Follicular Lymphoma Read More
WILMINGTON, DE — Veolia has officially launched one of the largest PFAS treatment facilities in the United States at the Stanton Water Treatment Plant in Delaware, addressing critical water contamination …
Veolia Unveils Landmark PFAS Treatment Facility in Delaware Read More
WILMINGTON, DE — The Chemours Company (NYSE: CC) issued an updated outlook for the second quarter of 2025, highlighting robust performance across several business segments. Notable gains are projected for …
Chemours Updates Second Quarter 2025 Outlook with Strong Gains in Key Segments Read More